Non-interventional study
An observational, Post-Authorisation Safety Study (PASS) to describe the safety and effectiveness of tabelecleucel in patients with Epstein-Barr Virus positive (EBV+) Post-Transplant Lymphoproliferative Disease (PTLD) in a real-world setting in Europe: EBVOLVE study
European Union
EU PAS number:
EUPAS1000000113
First published:
21/05/2025
StudyOngoing
Real world management of pain: Do patient-specific factors influence treatment decisions and its outcomes? (RELIEF)
Bosnia and Herzegovina
Croatia
Czechia
North Macedonia
Serbia
EU PAS number:
EUPAS1000000079
First published:
25/03/2024
StudyFinalised
CROSSROADS-1: Treatment Outcomes among Tezspire Users: A Claims Data Study (20230159)
United States
EU PAS number:
EUPAS1000000062
First published:
04/07/2025
StudyOngoing
CROSSROADS-2: Clinical Characteristics, Treatment Patterns, and Treatment Outcomes Among Users of Tezspire: An Electronic Medical Record (EMR) study (20220066)
United States
EU PAS number:
EUPAS1000000053
First published:
12/06/2025
StudyOngoing
TAK-620-4007: Retrospective Chart Review of Safety Outcomes Associated With Use of Maribavir in Patients With Post-transplant Refractory Cytomegalovirus (CMV) Infection and Comorbid Severe Chronic Kidney Disease (CKD) or Comorbid End-stage Renal Disease (ESRD), Including Patients on Peritoneal Dialysis or Hemodialysis
Austria
Belgium
Denmark
Estonia
France
Germany
Italy
Spain
United Kingdom
EU PAS number:
EUPAS1000000006
First published:
01/07/2025
StudyPlanned
Post Marketing Surveillance of Effectiveness (All-Cause Mortality) of Posaconazole Injection and Tablet Treatment of Invasive Aspergillosis in Chinese patients (MK-5592-141)
China
EU PAS number:
EUPAS108481
First published:
14/02/2025
StudyOngoing
Population-based retrospective nested case-control study evaluating effectiveness of GARDASIL™ /GARDASIL™9 against adult-onset recurrent respiratory papillomatosis (AoRRP) in Sweden, Denmark, and Norway (V503-088)
Denmark
Norway
Sweden
EU PAS number:
EUPAS48452
First published:
21/05/2025
StudyOngoing
International Active Surveillance Study: Native Estrogen Estetrol (E4) Safety Study (INAS-NEES)
Czechia
Germany
Hungary
Italy
Poland
Spain
Sweden
United Kingdom
United States
EU PAS number:
EUPAS49984
First published:
20/06/2025
StudyOngoing
The Multi-National Gilenya Pregnancy Exposure Registry in Multiple Sclerosis (Gilenya Pregnancy Registry)
Argentina
Australia
Austria
Canada
Cyprus
Czechia
Denmark
Finland
France
Germany
Greece
Hungary
Ireland
Italy
Lebanon
Mexico
Netherlands
Poland
Portugal
Russian Federation
Saudi Arabia
Spain
Sweden
Switzerland
United Arab Emirates
United Kingdom
United States
EU PAS number:
EUPAS2569
First published:
04/06/2025
StudyFinalised
EU Population-Based Cross-Sectional Survey in Migraine: ObserVational survey of the Epidemiology, tReatment and Care Of MigrainE (EU OVERCOME)
Germany
Spain
EU PAS number:
EUPAS37093
First published:
23/04/2024
StudyPlanned